Nawsherwan Mohammad: Recognizing TTP Before the ADAMTS13 Result Arrives
Nawsherwan Mohammad, Consultant Hematopathologist at Nanakaly Hospital, shared a post on LinkedIn about a recent article by Stephen MacDonald et al., published in BJHaem, adding:
“Suspected TTP is a medical emergency – don’t wait for ADAMTS13 to treat when clinical suspicion is high.
A practical summary of the 2026 BSH laboratory guidance on thrombotic thrombocytopenic purpura:
- Think TTP when thrombocytopenia plus microangiopathic haemolytic anaemia occur together.
- Look for marked thrombocytopenia, schistocytes, reticulocytosis, elevated LDH, low haptoglobin, and usually normal coagulation.
- Send a pre-treatment ADAMTS13 sample – ideally 3.2% sodium citrate, not EDTA – but never delay treatment.
- ADAMTS13 activity less than 10 IU/dL strongly supports TTP.
- 10–20 IU/dL is a grey zone, not an automatic negative.
- If less than 10 IU/dL, test anti-ADAMTS13 antibodies within 72 hours.
- Antibody-negative does not prove congenital TTP – genetic testing is required.
- For monitoring, use the same assay platform whenever possible.
Key message: rapid recognition, early sampling, and urgent treatment save lives.”
Title: Diagnosis and monitoring of thrombotic thrombocytopenic purpura: Guidance for laboratories from the British Society for Haematology
Authors: Stephen MacDonald, Thomas Pitchford, Deepak Singh, Rebekah Fretwell, P. Vince Jenkins, Caroline Lawrence, Richard Gooding, Sean Platton

Stay updated with Hemostasis Today.
-
Nov 19, 2026, 16:27263 PolyU Students and Staff Unite to Donate Blood – Hong Kong Red Cross Blood Transfusion Service
-
Nov 19, 2026, 16:16Billy Otieno: The Future of Blood Donation Lies Beyond Collection
-
Nov 19, 2026, 15:58Hema Goyal: Hematocon 2026 Bringing Together Knowledge, Innovation and Excellence in Hematology
-
Nov 19, 2026, 15:44Chukwuemeka Amarachi: Understanding Complex Blood Grouping Beyond Routine ABO And RhD Typing
-
Nov 19, 2026, 14:19Long-Read Sequencing Is Closing Diagnostic Gaps in Inherited Bleeding Disorders
-
Nov 19, 2026, 13:36Raja Prince: Protein S Silencing and the Future of Hemostatic Therapy
-
Nov 19, 2026, 13:26M. Sekip Altunkan: The Thrombotic Risk of Andexanet Alfa
-
Nov 19, 2026, 13:18Felice Gragnano: Personalizing Antiplatelet Therapy After PCI
-
Nov 19, 2026, 13:11When Postpartum Warning Signs Are Ignored – National Blood Clot Alliance